Newman Rachel A, Conley Patrick, Esakoff Tania, Grobman William, Haas David, Wapner Ronald, Chung Judith, Saade George, Bello Natalie A
University of Texas at Houston Health Science Center, Houston, Texas.
Smidt Heart Institute, Cedars Sinai Medical Center, Los Angeles, California.
Am J Perinatol. 2025 Jan 30. doi: 10.1055/a-2507-7428.
The association between paternal age and adverse pregnancy outcomes (APOs) has not been well studied. We sought to determine whether advanced paternal age (APA) is associated with adverse maternal or neonatal outcomes.
Secondary analysis of 8,863 pregnancies from the Nulliparous Pregnancy Outcomes Study Monitoring Mothers-to-Be (nuMoM2b) prospective cohort in which both maternal and paternal age at conception were known. APA was defined as age ≥ 40 years and AMA was defined as age ≥ 35 years. Composite maternal and fetal/neonatal APO outcomes were adjudicated by experts using previously defined methods. Univariable and multivariable logistic regression models were used to estimate the associations between APA, AMA, and their combination (AMA and APA), with the outcomes of interest (APO, fetal/neonatal, and combined APO or fetal/neonatal outcomes). Multivariable analyses were adjusted for covariates identified a priori: self-reported race and ethnicity, education, body mass index, maternal medical conditions, assisted reproductive technology (ART), and maternal age in APA only models.
APA in isolation was not significantly associated with maternal or fetal/neonatal adverse outcomes (adjusted odds ratio [aOR] = 1.08, 95% confidence interval [CI]: 0.89 - 1.32). In contrast, AMA pregnancies and pregnancies in which both parents were of advanced age were associated with significantly increased risk of maternal or fetal/neonatal adverse outcome (aOR = 1.37, 95% CI: 1.17 - 1.59, < 0.001 and aOR = 1.60, 95% CI: 1.25 - 2.05, < 0.001), respectively. Findings were similar when individuals who used assisted reproductive technology (ART) were excluded from analyses.
In our study of nulliparous birthing people, in contrast to AMA pregnancies, APA alone was not significantly associated with a heightened risk of maternal or fetal/neonatal APOs. However, pregnancies from both AMA and APA individuals demonstrated a trend toward a higher risk of APOs compared with AMA pregnancies. Further research is needed to delineate the mechanism driving this finding.
· There is an established association between older maternal age and increased risk of adverse pregnancy outcomes. Determining the influence of paternal age on pregnancy outcomes is of equal importance.. · Prior data are inconclusive on the association of APA and rates of miscarriage, fertilization rates, and aneuploidy, and to our knowledge, the associations with adverse pregnancy outcomes have not been previously examined.. · This study examines if APA (paternal age ≥ 40 years) is an independent risk factor for adverse pregnancy outcomes in a cohort of nulliparous birthing people..
父亲年龄与不良妊娠结局(APO)之间的关联尚未得到充分研究。我们试图确定父亲高龄(APA)是否与不良母体或新生儿结局相关。
对未生育孕妇结局研究监测准妈妈(nuMoM2b)前瞻性队列中的8863例妊娠进行二次分析,该队列中已知受孕时的母亲和父亲年龄。APA定义为年龄≥40岁,AMA定义为年龄≥35岁。复合母体和胎儿/新生儿APO结局由专家使用先前定义的方法进行判定。使用单变量和多变量逻辑回归模型来估计APA、AMA及其组合(AMA和APA)与感兴趣的结局(APO、胎儿/新生儿以及组合的APO或胎儿/新生儿结局)之间的关联。多变量分析针对事先确定的协变量进行了调整:自我报告的种族和族裔、教育程度、体重指数、母体疾病、辅助生殖技术(ART),以及仅在APA模型中的母亲年龄。
单独的APA与母体或胎儿/新生儿不良结局无显著关联(调整后的优势比[aOR]=1.08,95%置信区间[CI]:0.89-1.32)。相比之下,AMA妊娠以及父母双方均为高龄的妊娠与母体或胎儿/新生儿不良结局的风险显著增加相关(aOR=1.37,95%CI:1.17-1.59,P<0.001;aOR=1.60,95%CI:1.25-2.05,P<0.001)。当排除使用辅助生殖技术(ART)的个体进行分析时,结果相似。
在我们对未生育人群的研究中,与AMA妊娠不同,单独的APA与母体或胎儿/新生儿APO风险升高无显著关联。然而,AMA和APA个体的妊娠与AMA妊娠相比,APO风险有升高趋势。需要进一步研究来阐明导致这一发现的机制。
· 母亲年龄较大与不良妊娠结局风险增加之间存在既定关联。确定父亲年龄对妊娠结局的影响同样重要。· 先前的数据对于APA与流产率、受精率和非整倍体的关联尚无定论,据我们所知,此前尚未研究其与不良妊娠结局的关联。· 本研究探讨了APA(父亲年龄≥(40)岁)是否是未生育人群队列中不良妊娠结局的独立危险因素。